{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:58:01Z","timestamp":1792645081920,"version":"4.5.0"},"reference-count":280,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ijbiomac.2021.03.113","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T12:12:04Z","timestamp":1616501524000},"page":"582-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"special_numbering":"C","title":["The role of amyloid oligomers in neurodegenerative pathologies"],"prefix":"10.1016","volume":"181","author":[{"given":"Cameron","family":"Wells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Keon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lezanne","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijbiomac.2021.03.113_bb0005","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/19336896.2019.1569451","article-title":"The Prion 2018 round tables (II): A\u03b2, tau, \u03b1synuclein\u2026 are they prions, prion-like proteins, or what?","volume":"13","author":"Era\u00f1a","year":"2019","journal-title":"Prion"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb0015","doi-asserted-by":"crossref","DOI":"10.4161\/pri.27960","article-title":"Classifying prion and prion-like phenomena","volume":"8","author":"Harbi","year":"2014","journal-title":"Prion"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0020","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181415","article-title":"Congo Red and amyloids: history and relationship","volume":"39","author":"Yakupova","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0025","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1242\/jcs.051672","article-title":"Prion-like disorders: blurring the divide between transmissibility and infectivity","volume":"123","author":"Cushman","year":"2010","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.03.113_bb0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/13506129.2012.734345","article-title":"Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis","volume":"19","author":"Sipe","year":"2012","journal-title":"Amyloid"},{"issue":"271","key":"10.1016\/j.ijbiomac.2021.03.113_bb0035","article-title":"Prionoid proteins in the pathogenesis of neurodegenerative diseases","volume":"12","author":"Wells","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.03.113_bb0040","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/abbs\/gmt037","article-title":"Prion protein oligomer and its neurotoxicity","volume":"45","author":"Huang","year":"2013","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.03.113_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006557","article-title":"Reversible unfolding of infectious prion assemblies reveals the existence of an oligomeric elementary brick","volume":"13","author":"Igel-Egalon","year":"2017","journal-title":"PLOS Pathogens"},{"issue":"17","key":"10.1016\/j.ijbiomac.2021.03.113_bb0050","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1039\/C8SC05627G","article-title":"Direct observation of prion protein oligomer formation reveals an aggregation mechanism with multiple conformationally distinct species","volume":"10","author":"Sang","year":"2019","journal-title":"Chem. Sci."},{"issue":"14","key":"10.1016\/j.ijbiomac.2021.03.113_bb0055","doi-asserted-by":"crossref","first-page":"7831","DOI":"10.1073\/pnas.1916452117","article-title":"Dynamics of oligomer and amyloid fibril formation by yeast prion Sup35 observed by high-speed atomic force microscopy","volume":"117","author":"Konno","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.03.113_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030125","article-title":"In vitro and in vivo neurotoxicity of prion protein oligomers","volume":"3","author":"Simoneau","year":"2007","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.03.113_bb0065","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600014","article-title":"Copper-induced structural conversion templates prion protein oligomerization and neurotoxicity","volume":"2","author":"Yen","year":"2016","journal-title":"Sci. Adv."},{"issue":"13","key":"10.1016\/j.ijbiomac.2021.03.113_bb0070","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.03.113_bb0075","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.4161\/cc.8.11.8503","article-title":"Amyloid deposits: protection against toxic protein species?","volume":"8","author":"Treusch","year":"2009","journal-title":"Cell Cycle"},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.03.113_bb0080","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1074\/jbc.M109.069542","article-title":"Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation","volume":"285","author":"Wu","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6880","key":"10.1016\/j.ijbiomac.2021.03.113_bb0085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/416507a","article-title":"Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases","volume":"416","author":"Bucciantini","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer's disease and other dementias, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Nichols","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nicl.2017.04.001","article-title":"Neuro-degeneration profile of Alzheimer's patients: a brain morphometry study","volume":"15","author":"da Silva Filho","year":"2017","journal-title":"Neuroimage Clin."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.03.113_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008310","article-title":"Mitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer's disease","volume":"4","author":"Iijima-Ando","year":"2009","journal-title":"PLoS One"},{"issue":"36","key":"10.1016\/j.ijbiomac.2021.03.113_bb0105","doi-asserted-by":"crossref","first-page":"30317","DOI":"10.1074\/jbc.M112.365890","article-title":"Swedish Alzheimer mutation induces mitochondrial dysfunction mediated by HSP60 mislocalization of amyloid precursor protein (APP) and beta-amyloid","volume":"287","author":"Walls","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.03.113_bb0110","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1523\/JNEUROSCI.3699-09.2010","article-title":"Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila","volume":"30","author":"Zhao","year":"2010","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.03.113_bb0115","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron"},{"issue":"4978","key":"10.1016\/j.ijbiomac.2021.03.113_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.2218531","article-title":"Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides","volume":"250","author":"Yankner","year":"1990","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.03.113_bb0125","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1523\/JNEUROSCI.18-05-01743.1998","article-title":"Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester","volume":"18","author":"Savage","year":"1998","journal-title":"J. Neurosci."},{"issue":"16","key":"10.1016\/j.ijbiomac.2021.03.113_bb0130","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1523\/JNEUROSCI.5078-05.2006","article-title":"Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system","volume":"26","author":"Almeida","year":"2006","journal-title":"J. Neurosci."},{"issue":"6012","key":"10.1016\/j.ijbiomac.2021.03.113_bb0135","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0140","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410410106","article-title":"Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease","volume":"41","author":"Gomez-Isla","year":"1997","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.03.113_bb0150","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.0811698106","article-title":"Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques","volume":"106","author":"Koffie","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"19 Pt A","key":"10.1016\/j.ijbiomac.2021.03.113_bb0155","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.febslet.2015.07.013","article-title":"Structural, morphological, and functional diversity of amyloid oligomers","volume":"589","author":"Breydo","year":"2015","journal-title":"FEBS Lett."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.03.113_bb0160","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrn2494","article-title":"Thirty years of Alzheimer\u2019s disease genetics: the implications of systematic meta-analyses","volume":"9","author":"Bertram","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/abbi.1993.1112","article-title":"Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer\u2019s disease","volume":"301","author":"Miller","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","article-title":"Visualization of A\u03b242(43) and A\u03b240 in senile plaques with end-specific A\u03b2 monoclonals: Evidence that an initially deposited species is A\u03b242(43)","volume":"13","author":"Iwatsubo","year":"1994","journal-title":"Neuron"},{"issue":"13","key":"10.1016\/j.ijbiomac.2021.03.113_bb0175","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1074\/jbc.270.13.7013","article-title":"Amyloid \u03b2 protein (A\u03b2) in Alzheimer\u2019s disease brain: Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A\u03b240 or A\u03b242(43)","volume":"270","author":"Gravina","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0180","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1471-4159.2005.03578.x","article-title":"Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms","volume":"96","author":"Bentahir","year":"2006","journal-title":"J. Neurochem."},{"issue":"19","key":"10.1016\/j.ijbiomac.2021.03.113_bb0185","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1038\/emboj.2010.211","article-title":"Neurotoxicity of Alzheimer's disease A\u03b2 peptides is induced by small changes in the A\u03b242 to A\u03b240 ratio","volume":"29","author":"Kuperstein","year":"2010","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb0190","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0195","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1073\/pnas.222681699","article-title":"Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways","volume":"100","author":"Bitan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0200","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1523\/JNEUROSCI.4849-06.2007","article-title":"Abeta40 inhibits amyloid deposition in vivo","volume":"27","author":"Kim","year":"2007","journal-title":"J. Neurosci."},{"issue":"14","key":"10.1016\/j.ijbiomac.2021.03.113_bb0205","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1523\/JNEUROSCI.2907-13.2014","article-title":"Differential effects of synaptic and extrasynaptic NMDA receptors on Abeta-induced nitric oxide production in cerebrocortical neurons","volume":"34","author":"Molokanova","year":"2014","journal-title":"J. Neurosci."},{"issue":"27","key":"10.1016\/j.ijbiomac.2021.03.113_bb0210","doi-asserted-by":"crossref","first-page":"E2518","DOI":"10.1073\/pnas.1306832110","article-title":"Abeta induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss","volume":"110","author":"Talantova","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0215","first-page":"1071","article-title":"Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death","volume":"1071","author":"Wogulis","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.03.113_bb0220","doi-asserted-by":"crossref","first-page":"8585","DOI":"10.1074\/jbc.M110.172411","article-title":"A\u03b242 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete A\u03b242 species","volume":"286","author":"Jan","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.03.113_bb0225","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12551-017-0289-z","article-title":"Monomer-dependent secondary nucleation in amyloid formation","volume":"9","author":"Linse","year":"2017","journal-title":"Biophys. Rev."},{"issue":"5123","key":"10.1016\/j.ijbiomac.2021.03.113_bb0230","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.ijbiomac.2021.03.113_bb0235","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.03.113_bb0240","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.92.8.3586","article-title":"Quantitative analysis of senile plaques in Alzheimers disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome)","volume":"92","author":"Hyman","year":"1995","journal-title":"PNAS USA"},{"issue":"43","key":"10.1016\/j.ijbiomac.2021.03.113_bb0245","doi-asserted-by":"crossref","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","article-title":"Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid \u03b2 peptide","volume":"32","author":"Hashimoto","year":"2012","journal-title":"J. Neurosci."},{"issue":"89","key":"10.1016\/j.ijbiomac.2021.03.113_bb0250","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid\u03b2 peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.03.113_bb0255","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain","volume":"118","author":"Deane","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"204","key":"10.1016\/j.ijbiomac.2021.03.113_bb0260","article-title":"Role of tau as a microtubule-associated protein: structural and functional aspects","volume":"11","author":"Barbier","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"22","key":"10.1016\/j.ijbiomac.2021.03.113_bb0265","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1091\/mbc.e14-06-1099","article-title":"Single-molecule tracking of tau reveals fast kiss-and-hop interaction with microtubules in living neurons","volume":"25","author":"Janning","year":"2014","journal-title":"Mol. Biol. Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0270","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0197-4580(95)00025-A","article-title":"Tau domains, phosphorylation, and interactions with microtubules","volume":"16","author":"Mandelkow","year":"1995","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0275","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.celrep.2018.12.085","article-title":"Microtubules deform the nuclear membrane and disrupt nucleocytoplasmic transport in tau-mediated frontotemporal dementia","volume":"26","author":"Paonessa","year":"2019","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.03.113_bb0280","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1016\/S0021-9258(17)42989-9","article-title":"Phosphorylation affects the ability of tau protein to promote microtubule assembly","volume":"259","author":"Lindwall","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0285","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fnagi.2016.00262","article-title":"Tau structures","volume":"8","author":"Avila","year":"2016","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.03.113_bb0290","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J. Neuropathol. Experim. Neurol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.03.113_bb0295","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2353\/ajpath.2006.050840","article-title":"Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy","volume":"168","author":"Spires","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0300","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neures.2005.11.009","article-title":"Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer\u2019s disease","volume":"54","author":"Maeda","year":"2006","journal-title":"Neurosci. Res."},{"issue":"14","key":"10.1016\/j.ijbiomac.2021.03.113_bb0305","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1523\/JNEUROSCI.0587-07.2007","article-title":"Accumulation of pathological tau species and memory loss in a conditional model of tauopathy","volume":"27","author":"Berger","year":"2007","journal-title":"J. Neurosci."},{"issue":"26","key":"10.1016\/j.ijbiomac.2021.03.113_bb0310","doi-asserted-by":"crossref","first-page":"23063","DOI":"10.1074\/jbc.M111.237974","article-title":"Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease","volume":"286","author":"Patterson","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.03.113_bb0315","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.11-199851","article-title":"Identification of oligomers at early stages of tau aggregation in Alzheimer\u2019s disease","volume":"26","author":"Lasagna-Reeves","year":"2012","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0320","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Lasagna-Reeves","year":"2011","journal-title":"Mol. Neurodegener."},{"issue":"22","key":"10.1016\/j.ijbiomac.2021.03.113_bb0325","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1089\/neu.2015.4262","article-title":"Tau oligomers derived from traumatic brain injury cause cognitive impairment and accelerate onset of pathology in Htau mice","volume":"33","author":"Gerson","year":"2016","journal-title":"J. Neurotrauma"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb0330","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/brain\/awx342","article-title":"Potentiating tangle formation reduces acute toxicity of soluble tau species in the rat","volume":"141","author":"d'Orange","year":"2018","journal-title":"Brain"},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0335","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.3233\/JAD-132477","article-title":"Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds","volume":"40","author":"Castillo-Carranza","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0340","series-title":"Contribution \u00e0 l'\u00e9tude de l'anatomie pathologique du locus niger de S\u00f6mmering, Paris","author":"Tr\u00e9tiakoff","year":"1919"},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.03.113_bb0345","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/cne.23901","article-title":"Brain region-dependent differential expression of alpha-synuclein","volume":"524","author":"Taguchi","year":"2016","journal-title":"J. Comp. Neurol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb0350","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0355","first-page":"1","article-title":"a-Synuclein in Parkinson\u2019s Disease","volume":"4","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0360","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1038\/srep09228","article-title":"Structure based aggregation studies reveal the presence of helix-rich intermediate during \u03b1-synuclein aggregation","volume":"5","author":"Ghosh","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0365","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3233\/JPD-171103","article-title":"The role of lipids interacting with alpha-synuclein in the pathogenesis of Parkinson\u2019s disease","volume":"7","author":"Galvagnion","year":"2017","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0370","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jmb.2005.10.071","article-title":"Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy","volume":"355","author":"Apetri","year":"2006","journal-title":"J. Mol. Biol."},{"issue":"29","key":"10.1016\/j.ijbiomac.2021.03.113_bb0375","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.1002\/anie.201400491","article-title":"Co-existence of two different \u03b1-synuclein oligomers with different core structures determined by hydrogen\/deuterium exchange mass spectrometry","volume":"53","author":"Paslawski","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.03.113_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218261","article-title":"E46K mutant \u03b1-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type \u03b1-synuclein in Drosophila models of Parkinson\u2019s disease","volume":"14","author":"Sakai","year":"2019","journal-title":"PLoS One"},{"issue":"38","key":"10.1016\/j.ijbiomac.2021.03.113_bb0385","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1021\/bi010616g","article-title":"Effect of familial Parkinson\u2019s disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein","volume":"40","author":"Li","year":"2001","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.03.113_bb0390","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"Alpha-synuclein, especially the Parkinson\u2019s disease-associated mutants, forms pore-like annular and tubular protofibrils","volume":"322","author":"Lashuel","year":"2002","journal-title":"J. Mol. Biol."},{"issue":"31","key":"10.1016\/j.ijbiomac.2021.03.113_bb0395","doi-asserted-by":"crossref","first-page":"24065","DOI":"10.1074\/jbc.M002413200","article-title":"Wild-type but not Parkinson\u2019s disease-related ala-53 \u2192 Thr mutant alpha-synuclein protects neuronal cells from apoptotic stimuli","volume":"275","author":"da Costa","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.03.113_bb0400","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1523\/JNEUROSCI.3809-03.2004","article-title":"Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway","volume":"24","author":"Lee","year":"2004","journal-title":"J. Neurosci."},{"issue":"26","key":"10.1016\/j.ijbiomac.2021.03.113_bb0405","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1021\/bi0102398","article-title":"Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson\u2019s disease","volume":"40","author":"Volles","year":"2001","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.03.113_bb0410","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/039463200902200405","article-title":"Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils","volume":"22","author":"Wilms","year":"2009","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0415","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0420","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12868-015-0192-0","article-title":"Exogenous alpha-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes","volume":"16","author":"Rannikko","year":"2015","journal-title":"BMC Neurosci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.03.113_bb0425","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.03.113_bb0430","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"Macdonald","year":"1993","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0435","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","article-title":"Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo","volume":"90","author":"Scherzinger","year":"1997","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0440","first-page":"16","article-title":"Phenotypic characterization of individuals with 30\u201340 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36\u201339 repeats","volume":"59","author":"Rubinsztein","year":"1996","journal-title":"Am. J. Human Genet."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb0445","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng0297-197","article-title":"Instability of highly expanded CAG repeats in mice transgenic for the Huntington\u2019s disease mutation","volume":"15","author":"Mangiarini","year":"1997","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb0450","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1503","article-title":"Polyglutamine expansion of huntingtin impairs its nuclear export","volume":"37","author":"Cornett","year":"2005","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.03.113_bb0455","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1074\/jbc.M112.413575","article-title":"An N-terminal nuclear export signal regulates trafficking and aggregation of Huntingtin (Htt) protein exon 1","volume":"288","author":"Zheng","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"a","key":"10.1016\/j.ijbiomac.2021.03.113_bb0460","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ng0595-104","article-title":"Cellular localisation of the Huntington\u2019s disease protein and discrimination of the normal and mutated forms","volume":"10","author":"Trottier","year":"1995","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.03.113_bb0465","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00005072-198809000-00003","article-title":"Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington\u2019s disease","volume":"47","author":"de la Monte","year":"1988","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3\u20134","key":"10.1016\/j.ijbiomac.2021.03.113_bb0470","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainresbull.2010.04.003","article-title":"Striatal and white matter predictors of estimated diagnosis for Huntington disease","volume":"82","author":"Paulsen","year":"2010","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1755-5949.2008.00068.x","article-title":"Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease","volume":"15","author":"Squitieri","year":"2009","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.03.113_bb0480","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.molcel.2016.07.022","article-title":"Soluble Oligomers of polyQ-expanded huntingtin target a multiplicity of key cellular factors","volume":"63","author":"Kim","year":"2016","journal-title":"Mol. Cell"},{"issue":"7010","key":"10.1016\/j.ijbiomac.2021.03.113_bb0485","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0490","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3753","article-title":"Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress","volume":"4","author":"Leitman","year":"2013","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0495","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.ijbiomac.2021.03.113_bb0500","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1093\/hmg\/ddg346","article-title":"Autophagy regulates the processing of amino terminal huntingtin fragments","volume":"12","author":"Qin","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.03.113_bb0505","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0510","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40478-018-0579-0","article-title":"Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers","volume":"6","author":"Frick","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0515","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5607\/en.2015.24.3.226","article-title":"Modulation of SOD1 subcellular localization by transfection with wild- or mutant-type SOD1 in primary neuron and astrocyte cultures from ALS mice","volume":"24","author":"Lee","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0520","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fncel.2016.00290","article-title":"FUS mislocalization and vulnerability to DNA damage in ALS patients derived hiPSCs and aging motoneurons","volume":"10","author":"Higelin","year":"2016","journal-title":"Front. Cell. Neurosci."},{"issue":"5796","key":"10.1016\/j.ijbiomac.2021.03.113_bb0525","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.03.113_bb0530","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archneur.65.5.636","article-title":"Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis","volume":"65","author":"Geser","year":"2008","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb0535","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1523\/JNEUROSCI.4988-09.2010","article-title":"Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis","volume":"30","author":"Barmada","year":"2010","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.03.113_bb0540","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrneurol.2011.150","article-title":"Clinical genetics of amyotrophic lateral sclerosis: what do we really know?","volume":"7","author":"Andersen","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0545","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pneurobio.2016.09.004","article-title":"TDP-43\/FUS in motor neuron disease: complexity and challenges","volume":"145\u2013146","author":"Guerrero","year":"2016","journal-title":"Prog. Neurobiol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2021.03.113_bb0550","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1212\/WNL.0b013e3181bbff05","article-title":"Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort","volume":"73","author":"Ticozzi","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0555","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40478-016-0358-8","article-title":"Pathogenesis of FUS-associated ALS and FTD: insights from rodent models","volume":"4","author":"Nolan","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.03.113_bb0560","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrneurol.2014.78","article-title":"The role of FUS gene variants in neurodegenerative diseases","volume":"10","author":"Deng","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb0565","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/archneurol.2009.329","article-title":"FUS mutations in familial amyotrophic lateral sclerosis in the Netherlands","volume":"67","author":"Groen","year":"2010","journal-title":"Arch. Neurol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.03.113_bb0570","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1474-4422(10)70195-2","article-title":"TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"9","author":"Mackenzie","year":"2010","journal-title":"Lancet Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0575","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/21678421.2013.778548","article-title":"Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis","volume":"14","author":"Ravits","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb0580","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"issue":"33","key":"10.1016\/j.ijbiomac.2021.03.113_bb0585","doi-asserted-by":"crossref","first-page":"8770","DOI":"10.1073\/pnas.1705091114","article-title":"Atomic structure of a toxic, oligomeric segment of SOD1 linked to amyotrophic lateral sclerosis (ALS)","volume":"114","author":"Sangwan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"51","key":"10.1016\/j.ijbiomac.2021.03.113_bb0590","doi-asserted-by":"crossref","first-page":"20913","DOI":"10.1073\/pnas.1218792109","article-title":"Out-of-register \u03b2-sheets suggest a pathway to toxic amyloid aggregates","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0595","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0959-440X(99)00049-4","article-title":"Amyloid fibrillogenesis: themes and variations","volume":"10","author":"Rochet","year":"2000","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"18","key":"10.1016\/j.ijbiomac.2021.03.113_bb0600","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1073\/pnas.1800187115","article-title":"Large SOD1 aggregates, unlike trimeric SOD1, do not impact cell viability in a model of amyotrophic lateral sclerosis","volume":"115","author":"Zhu","year":"2018","journal-title":"PNAS"},{"issue":"499","key":"10.1016\/j.ijbiomac.2021.03.113_bb0605","article-title":"Susceptibility of mutant SOD1 to form a destabilized monomer predicts cellular aggregation and toxicity but not in vitro aggregation propensity","volume":"10","author":"McAlary","year":"2016","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb0610","doi-asserted-by":"crossref","first-page":"33A","DOI":"10.1016\/j.bpj.2013.11.258","article-title":"Post-translational modifications promote formation of SOD1 oligomers with potential toxicity in ALS","volume":"106","author":"Dokholyan","year":"2014","journal-title":"Biophys. J."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0615","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1073\/pnas.1516725113","article-title":"Nonnative SOD1 trimer is toxic to motor neurons in a model of amyotrophic lateral sclerosis","volume":"113","author":"Proctor","year":"2016","journal-title":"PNAS USA"},{"issue":"18","key":"10.1016\/j.ijbiomac.2021.03.113_bb0620","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.1093\/hmg\/ddv239","article-title":"Subcellular localization and RNAs determine FUS architecture in different cellular compartments","volume":"24","author":"Yang","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"5918","key":"10.1016\/j.ijbiomac.2021.03.113_bb0625","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science (New York, N.Y.)"},{"issue":"50","key":"10.1016\/j.ijbiomac.2021.03.113_bb0630","doi-asserted-by":"crossref","first-page":"17809","DOI":"10.1073\/pnas.1414004111","article-title":"Self-assembled FUS binds active chromatin and regulates gene transcription","volume":"111","author":"Yang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"16","key":"10.1016\/j.ijbiomac.2021.03.113_bb0635","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1038\/emboj.2010.143","article-title":"ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import","volume":"29","author":"Dormann","year":"2010","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0640","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00401-013-1089-6","article-title":"Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid","volume":"125","author":"Bigio","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.03.113_bb0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000614","article-title":"Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS\/TLS","volume":"9","author":"Sun","year":"2011","journal-title":"PLoS Biol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2021.03.113_bb0650","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1093\/hmg\/ddu243","article-title":"Multistep process of FUS aggregation in the cell cytoplasm involves RNA-dependent and RNA-independent mechanisms","volume":"23","author":"Shelkovnikova","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.03.113_bb0655","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1083\/jcb.143.7.1883","article-title":"Aggresomes: a cellular response to misfolded proteins","volume":"143","author":"Johnston","year":"1998","journal-title":"J. Cell Biol."},{"issue":"21","key":"10.1016\/j.ijbiomac.2021.03.113_bb0660","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1093\/hmg\/ddq335","article-title":"Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules","volume":"19","author":"Bosco","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.03.113_bb0665","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.cell.2015.07.047","article-title":"A liquid-tosolid phase transition of the ALS protein FUS accelerated by disease mutation","volume":"162","author":"Patel","year":"2015","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.ijbiomac.2021.03.113_bb0670","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1074\/jbc.RA118.005889","article-title":"Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation","volume":"294","author":"French","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0675","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5824","article-title":"Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients","volume":"5","author":"Fang","year":"2014","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.03.113_bb0680","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nsmb.2053","article-title":"An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity","volume":"18","author":"Guo","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0685","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neulet.2019.04.001","article-title":"The metastability of the proteome of spinal motor neurons underlies their selective vulnerability in ALS","volume":"704","author":"Yerbury","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.03.113_bb0690","first-page":"1263","article-title":"Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species","volume":"127","author":"Scotter","year":"2014","journal-title":"J. Cell Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.03.113_bb0695","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1096\/fj.201700292RR","article-title":"Quantitative assessment of the degradation of aggregated TDP-43 mediated by the ubiquitin proteasome system and macroautophagy","volume":"31","author":"Cascella","year":"2017","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0700","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-013-1149-y","article-title":"Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons","volume":"126","author":"Almeida","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.03.113_bb0705","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1007\/s12035-015-9537-z","article-title":"Parkin protects against misfolded SOD1 toxicity by promoting its aggresome formation and autophagic clearance","volume":"53","author":"Yung","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0710","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2018.04.006","article-title":"Autophagy as a common pathway in amyotrophic lateral sclerosis","volume":"697","author":"Nguyen","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"52","key":"10.1016\/j.ijbiomac.2021.03.113_bb0715","doi-asserted-by":"crossref","first-page":"44441","DOI":"10.1074\/jbc.M111.237115","article-title":"Regulation of autophagy by neuropathological protein TDP-43","volume":"286","author":"Bose","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.03.113_bb0720","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/brain\/awz078","article-title":"The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?","volume":"142","author":"Hergesheimer","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0725","series-title":"TDP-43 Post-translational Modifications in Health and Disease","first-page":"279","author":"Buratti","year":"2018"},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0730","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1038\/ncomms6845","article-title":"An acetylation switch controls TDP-43 function and aggregation propensity","volume":"6","author":"Cohen","year":"2015","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.ijbiomac.2021.03.113_bb0735","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1089\/ars.2016.6978","article-title":"Aspirin-mediated acetylation protects against multiple neurodegenerative pathologies by impeding protein aggregation","volume":"27","author":"Ayyadevara","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0740","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.nbd.2016.06.006","article-title":"Structural insights into the multi-determinant aggregation of TDP-43 in motor neuron-like cells","volume":"94","author":"Bozzo","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.03.113_bb0745","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/emboj.2011.471","article-title":"Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking","volume":"31","author":"Cohen","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0750","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neures.2015.12.006","article-title":"Phosphorylated TDP-43 becomes resistant to cleavage by calpain: a regulatory role for phosphorylation in TDP-43 pathology of ALS\/FTLD","volume":"107","author":"Yamashita","year":"2016","journal-title":"Neurosci. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0755","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","article-title":"Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications","volume":"17","author":"Chia","year":"2018","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.03.113_bb0760","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/stem.2388","volume":"34","author":"Dafinca","year":"2016","journal-title":"Stem Cells"},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.03.113_bb0765","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","article-title":"C9orf72-mediated ALS and FTD: multiple pathways to disease","volume":"14","author":"Balendra","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.03.113_bb0770","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.15252\/embj.201593350","article-title":"Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death","volume":"35","author":"Sellier","year":"2016","journal-title":"EMBO J."},{"issue":"15","key":"10.1016\/j.ijbiomac.2021.03.113_bb0775","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.15252\/embj.201694401","article-title":"The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy","volume":"35","author":"Webster","year":"2016","journal-title":"EMBO J."},{"issue":"6279","key":"10.1016\/j.ijbiomac.2021.03.113_bb0780","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.aaf1064","article-title":"C9orf72 is required for proper macrophage and microglial function in mice","volume":"351","author":"O\u2019Rourke","year":"2016","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.ijbiomac.2021.03.113_bb0785","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1091\/mbc.e16-01-0003","article-title":"C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling","volume":"27","author":"Amick","year":"2016","journal-title":"Mol. Biol. Cell"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.03.113_bb0790","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.neuron.2014.07.041","article-title":"Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD\/ALS","volume":"83","author":"Su","year":"2014","journal-title":"Neuron"},{"issue":"7491","key":"10.1016\/j.ijbiomac.2021.03.113_bb0795","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature13124","article-title":"C9orf72 nucleotide repeat structures initiate molecular cascades of disease","volume":"507","author":"Haeusler","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0800","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/srep01016","article-title":"C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes","volume":"2","author":"Fratta","year":"2012","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0805","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00401-017-1793-8","article-title":"Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis","volume":"135","author":"Saberi","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.03.113_bb0810","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00401-013-1189-3","article-title":"Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins","volume":"126","author":"Mori","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0815","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","article-title":"Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis","volume":"79","author":"Ling","year":"2013","journal-title":"Neuron"},{"issue":"6125","key":"10.1016\/j.ijbiomac.2021.03.113_bb0820","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.1232927","article-title":"The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS","volume":"339","author":"Mori","year":"2013","journal-title":"Science"},{"issue":"7043","key":"10.1016\/j.ijbiomac.2021.03.113_bb0825","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature03680","article-title":"Structure of the cross-beta spine of amyloid-like fibrils","volume":"435","author":"Nelson","year":"2005","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.ijbiomac.2021.03.113_bb0830","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1042\/BCJ20160868","article-title":"The growth of amyloid fibrils: rates and mechanisms","volume":"476","author":"Buell","year":"2019","journal-title":"Biochem. J."},{"issue":"44","key":"10.1016\/j.ijbiomac.2021.03.113_bb0835","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.1021\/bi500695g","article-title":"Mechanism of amyloid-beta fibril elongation","volume":"53","author":"Gurry","year":"2014","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0840","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0925-4439(00)00029-6","article-title":"Alzheimer\u2019s amyloid fibrils: structure and assembly","volume":"1502","author":"Serpell","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.03.113_bb0845","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1074-5521(97)90303-3","article-title":"Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer\u2019s disease amyloid-beta protein","volume":"4","author":"Harper","year":"1997","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0850","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0006-3495(98)77812-9","article-title":"Structural analysis of Alzheimer\u2019s \u03b2(1\u201340) amyloid: protofilament assembly of tubular fibrils","volume":"74","author":"Malinchik","year":"1998","journal-title":"Biophys. J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb0855","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0006-3495(03)74550-0","article-title":"A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy","volume":"85","author":"Khurana","year":"2003","journal-title":"Biophys. J."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.03.113_bb0860","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070521","article-title":"Conformational stability of fibrillar amyloid-beta oligomers via protofilament pair formation \u2013 a systematic computational study","volume":"8","author":"Kahler","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0865","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cell.2010.11.050","article-title":"Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions","volume":"144","author":"Olzscha","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0870","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1750-1326-6-65","article-title":"Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2\/Shank3 scaffold","volume":"6","author":"Grabrucker","year":"2011","journal-title":"Mol. Neurodegener."},{"issue":"6269","key":"10.1016\/j.ijbiomac.2021.03.113_bb0875","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1126\/science.aad2033","article-title":"Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA","volume":"351","author":"Woerner","year":"2016","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.03.113_bb0880","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00109-003-0464-5","article-title":"Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution","volume":"81","author":"Stefani","year":"2003","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.03.113_bb0885","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.str.2010.08.009","article-title":"Biology of amyloid: structure, function, and regulation","volume":"18","author":"Greenwald","year":"2010","journal-title":"Structure"},{"issue":"14","key":"10.1016\/j.ijbiomac.2021.03.113_bb0890","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2174\/1567205015666181004143432","article-title":"The implications of autophagy in Alzheimer\u2019s disease","volume":"15","author":"Hamano","year":"2018","journal-title":"Curr. Alzheimer Res."},{"issue":"31","key":"10.1016\/j.ijbiomac.2021.03.113_bb0895","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"PNAS USA"},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.03.113_bb0900","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1083\/jcb.200501085","article-title":"A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice","volume":"169","author":"Kieran","year":"2005","journal-title":"J. Cell Biol."},{"issue":"43","key":"10.1016\/j.ijbiomac.2021.03.113_bb0905","doi-asserted-by":"crossref","first-page":"41032","DOI":"10.1074\/jbc.M205809200","article-title":"Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization","volume":"277","author":"Poirier","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"30","key":"10.1016\/j.ijbiomac.2021.03.113_bb0910","doi-asserted-by":"crossref","first-page":"9696","DOI":"10.1021\/acs.jpcb.5b04822","article-title":"Oligomer formation of toxic and functional amyloid peptides studied with atomistic simulations","volume":"119","author":"Carballo-Pacheco","year":"2015","journal-title":"J. Phys. Chem. B"},{"issue":"5938","key":"10.1016\/j.ijbiomac.2021.03.113_bb0915","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1126\/science.1173155","article-title":"Functional amyloids as natural storage of peptide hormones in pituitary secretory granules","volume":"325","author":"Maji","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb0920","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0040006","article-title":"Functional amyloid formation within mammalian tissue","volume":"4","author":"Fowler","year":"2006","journal-title":"PLoS Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0925","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.bpj.2014.12.013","article-title":"Alzheimer\u2019s protective A2T mutation changes the conformational landscape of the A\u03b2\u2081\u208b\u2084\u2082 monomer differently than does the A2V mutation","volume":"108","author":"Das","year":"2015","journal-title":"Biophys. J."},{"issue":"17","key":"10.1016\/j.ijbiomac.2021.03.113_bb0930","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1016\/j.bmc.2005.05.037","article-title":"Protein oligomerization: how and why","volume":"13","author":"Ali","year":"2005","journal-title":"Bioorg. Med. Chem."},{"issue":"31","key":"10.1016\/j.ijbiomac.2021.03.113_bb0935","doi-asserted-by":"crossref","first-page":"8160","DOI":"10.1523\/JNEUROSCI.4809-05.2006","article-title":"Prefibrillar amyloid aggregates could be generic toxins in higher organisms","volume":"26","author":"Baglioni","year":"2006","journal-title":"J. Neurosci."},{"issue":"35","key":"10.1016\/j.ijbiomac.2021.03.113_bb0940","doi-asserted-by":"crossref","first-page":"14745","DOI":"10.1073\/pnas.0905127106","article-title":"Structure-neurotoxicity relationships of amyloid beta-protein oligomers","volume":"106","author":"Ono","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0945","doi-asserted-by":"crossref","first-page":"260787","DOI":"10.1155\/2013\/260787","article-title":"Trimeric tau is toxic to human neuronal cells at low nanomolar concentrations","volume":"2013","author":"Tian","year":"2013","journal-title":"Int. J. Cell Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0950","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/jnc.13443","article-title":"Membrane-bound tetramer and trimer A\u03b2 oligomeric species correlate with toxicity towards cultured neurons","volume":"136","author":"Jana","year":"2016","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb0955","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chembiol.2012.02.003","article-title":"Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships","volume":"19","author":"Bemporad","year":"2012","journal-title":"Chem. Biol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.03.113_bb0960","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1021\/cb500505m","article-title":"Toxicity of protein oligomers is rationalized by a function combining size and surface hydrophobicity","volume":"9","author":"Mannini","year":"2014","journal-title":"ACS Chem. Biol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.03.113_bb0965","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1021\/cb1001203","article-title":"ANS binding reveals common features of cytotoxic amyloid species","volume":"5","author":"Bolognesi","year":"2010","journal-title":"ACS Chem. Biol."},{"issue":"31","key":"10.1016\/j.ijbiomac.2021.03.113_bb0970","doi-asserted-by":"crossref","first-page":"12479","DOI":"10.1073\/pnas.1117799109","article-title":"Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers","volume":"109","author":"Mannini","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"15","key":"10.1016\/j.ijbiomac.2021.03.113_bb0975","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1128\/MCB.01187-10","article-title":"Sequestration of toxic oligomers by HspB1 as a cytoprotective mechanism","volume":"31","author":"Ojha","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0980","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00098","article-title":"Chaperones as suppressors of protein misfolded oligomer toxicity","volume":"10","author":"Mannini","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"51","key":"10.1016\/j.ijbiomac.2021.03.113_bb0985","doi-asserted-by":"crossref","first-page":"15436","DOI":"10.1021\/bi0204185","article-title":"Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance","volume":"41","author":"Antzutkin","year":"2002","journal-title":"Biochemistry"},{"issue":"35","key":"10.1016\/j.ijbiomac.2021.03.113_bb0990","doi-asserted-by":"crossref","first-page":"22364","DOI":"10.1074\/jbc.272.35.22364","article-title":"Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate","volume":"272","author":"Walsh","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb0995","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.03.113_bb1000","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nprot.2010.72","article-title":"Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer\u2019s disease research","volume":"5","author":"Jan","year":"2010","journal-title":"Nat. Protoc."},{"issue":"25","key":"10.1016\/j.ijbiomac.2021.03.113_bb1005","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.1021\/ja502529m","article-title":"Amyloid oligomers and protofibrils, but not filaments, self-replicate from native lysozyme","volume":"136","author":"Mulaj","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb1010","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.celrep.2013.09.043","article-title":"Widespread aggregation and neurodegenerative diseases are associated with supersaturated proteins","volume":"5","author":"Ciryam","year":"2013","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb1015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tips.2014.12.004","article-title":"Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases","volume":"36","author":"Ciryam","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.03.113_bb1020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002447","article-title":"Electrostatic repulsion governs TDP-43 C-terminal domain aggregation","volume":"14","author":"Mompe\u00e1n","year":"2016","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb1025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002338","article-title":"ALS-causing mutations significantly perturb the self-assembly and interaction with nucleic acid of the intrinsically disordered prion-like domain of TDP-43","volume":"14","author":"Lim","year":"2016","journal-title":"PLoS Biol."},{"issue":"17","key":"10.1016\/j.ijbiomac.2021.03.113_bb1030","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1016\/j.febslet.2005.05.036","article-title":"Charge substitution shows that repulsive electrostatic interactions impede the oligomerization of Alzheimer amyloid peptides","volume":"579","author":"Guo","year":"2005","journal-title":"FEBS Lett."},{"issue":"63","key":"10.1016\/j.ijbiomac.2021.03.113_bb1035","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.1039\/C8CC02204F","article-title":"Secondary nucleation in amyloid formation","volume":"54","author":"Tornquist","year":"2018","journal-title":"Chem. Commun. (Camb.)"},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.03.113_bb1040","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41557-018-0031-x","article-title":"Cholesterol catalyses Abeta42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes","volume":"10","author":"Habchi","year":"2018","journal-title":"Nat. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.03.113_bb1045","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.bbamem.2017.05.012","article-title":"Lipid membranes catalyse the fibril formation of the amyloid-beta (1-42) peptide through lipid-fibril interactions that reinforce secondary pathways","volume":"1859","author":"Lindberg","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.03.113_bb1050","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.bpj.2010.01.063","article-title":"Retardation of Abeta fibril formation by phospholipid vesicles depends on membrane phase behavior","volume":"98","author":"Hellstrand","year":"2010","journal-title":"Biophys. J."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.03.113_bb1055","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1111\/j.1742-4658.2009.07057.x","article-title":"Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cord","volume":"276","author":"Zhai","year":"2009","journal-title":"FEBS J."},{"issue":"13","key":"10.1016\/j.ijbiomac.2021.03.113_bb1060","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","article-title":"Dyslipidemia is a protective factor in amyotrophic lateral sclerosis","volume":"70","author":"Dupuis","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb1065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fncel.2014.00025","article-title":"A plural role for lipids in motor neuron diseases: energy, signaling and structure","volume":"8","author":"Schmitt","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb1070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017397","article-title":"DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice","volume":"6","author":"Arsenault","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.03.113_bb1075","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.neuint.2011.06.012","article-title":"The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson\u2019s disease","volume":"59","author":"Ozsoy","year":"2011","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.03.113_bb1080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061626","article-title":"The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis","volume":"8","author":"Yip","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb1085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1083\/jcb.200207113","article-title":"Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts","volume":"160","author":"Ehehalt","year":"2003","journal-title":"J. Cell Biol."},{"issue":"33","key":"10.1016\/j.ijbiomac.2021.03.113_bb1090","doi-asserted-by":"crossref","first-page":"11776","DOI":"10.1021\/ja505502e","article-title":"Surface effects on aggregation kinetics of amyloidogenic peptides","volume":"136","author":"Vacha","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.03.113_bb1095","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/acs.jpcb.6b10189","article-title":"From Abeta filament to fibril: molecular mechanism of surface-activated secondary nucleation from all-atom MD simulations","volume":"121","author":"Schwierz","year":"2017","journal-title":"J. Phys. Chem. B"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb1100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nsmb.2971","article-title":"A molecular chaperone Brichos breaks the catalytic cycle that generates toxic A\u03b2 oligomers","volume":"22","author":"Cohen","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.03.113_bb1105","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau3112","article-title":"Secondary nucleation and elongation occur at different sites on Alzheimer\u2019s amyloid-\u03b2 aggregates","volume":"5","author":"Scheidt","year":"2019","journal-title":"Science advances"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb1110","doi-asserted-by":"crossref","first-page":"E200","DOI":"10.1073\/pnas.1615613114","article-title":"Systematic development of small molecules to inhibit specific microscopic steps of Abeta42 aggregation in Alzheimer\u2019s disease","volume":"114","author":"Habchi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"27","key":"10.1016\/j.ijbiomac.2021.03.113_bb1115","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1039\/C8SC01479E","article-title":"Origin of metastable oligomers and their effects on amyloid fibril self-assembly","volume":"9","author":"Hasecke","year":"2018","journal-title":"Chem. Sci."},{"issue":"47","key":"10.1016\/j.ijbiomac.2021.03.113_bb1120","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1021\/bi1016233","article-title":"Preparation and characterization of neurotoxic tau oligomers","volume":"49","author":"Lasagna-Reeves","year":"2010","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.03.113_bb1125","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jmb.2008.09.063","article-title":"Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Abeta fibrils and protofibrils","volume":"384","author":"Arimon","year":"2008","journal-title":"J. Mol. Biol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.03.113_bb1130","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1172\/JCI35781","article-title":"Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease","volume":"118","author":"Lo Bianco","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.03.113_bb1135","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/hmg\/10.12.1307","article-title":"Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington\u2019s disease","volume":"10","author":"Sittler","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"5556","key":"10.1016\/j.ijbiomac.2021.03.113_bb1140","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.1067389","article-title":"Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson\u2019s disease","volume":"295","author":"Auluck","year":"2002","journal-title":"Science"},{"issue":"37","key":"10.1016\/j.ijbiomac.2021.03.113_bb1145","doi-asserted-by":"crossref","first-page":"31608","DOI":"10.1074\/jbc.M112.393157","article-title":"BRICHOS domains efficiently delay fibrillation of amyloid \u03b2-peptide","volume":"287","author":"Willander","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.03.113_bb1150","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1096\/fj.06-7986com","article-title":"The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures","volume":"21","author":"Yerbury","year":"2007","journal-title":"FASEB J."},{"issue":"13","key":"10.1016\/j.ijbiomac.2021.03.113_bb1155","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1074\/jbc.M115.689539","article-title":"Clusterin binds to Abeta1-42 oligomers with high affinity and interferes with peptide aggregation by inhibiting primary and Secondary Nucleation","volume":"291","author":"Beeg","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.03.113_bb1160","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.03.113_bb1165","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"issue":"35","key":"10.1016\/j.ijbiomac.2021.03.113_bb1170","doi-asserted-by":"crossref","first-page":"E5212","DOI":"10.1073\/pnas.1608045113","article-title":"Holdase activity of secreted Hsp70 masks amyloid-beta42 neurotoxicity in Drosophila","volume":"113","author":"Fernandez-Funez","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2021.03.113_bb1175","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jns.2012.05.030","article-title":"Mitochondria, oxidative stress and neurodegeneration","volume":"322","author":"Federico","year":"2012","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb1180","article-title":"Abnormalities of mitochondrial dynamics in neurodegenerative diseases","volume":"6","author":"Gao","year":"2017","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.03.113_bb1185","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1042\/BST20180025","article-title":"Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention","volume":"46","author":"Briston","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb1190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1326-5-24","article-title":"Heat shock protein 90 in neurodegenerative diseases","volume":"5","author":"Luo","year":"2010","journal-title":"Mol. Neurodegener."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.03.113_bb1195","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1074\/jbc.M511018200","article-title":"Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice","volume":"281","author":"Lee","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb1200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1471-4159.2006.04157.x","article-title":"Monoclonal antibodies that target pathological assemblies of Abeta","volume":"100","author":"Lambert","year":"2007","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.03.113_bb1205","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2007.02.029","article-title":"Alzheimer\u2019s disease-type neuronal tau hyperphosphorylation induced by Abeta oligomers","volume":"29","author":"De Felice","year":"2008","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.03.113_bb1210","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/cn300122k","article-title":"Synapse-binding subpopulations of A\u03b2 oligomers sensitive to peptide assembly blockers and scFv antibodies","volume":"3","author":"Velasco","year":"2012","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb1215","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.neurobiolaging.2014.12.002","article-title":"Isolation and characterization of antibody fragments selective for toxic oligomeric tau","volume":"36","author":"Tian","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb1220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jnc.12175","article-title":"Monoclonal antibodies selective for alpha-synuclein oligomers\/protofibrils recognize brain pathology in Lewy body disorders and alpha-synuclein transgenic mice with the disease-causing A30P mutation","volume":"126","author":"Fagerqvist","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb1225","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2014.05.009","article-title":"Immunotherapy targeting alpha-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] alpha-synuclein mice","volume":"69","author":"Lindstrom","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb1230","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-015-0008-9","article-title":"Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy","volume":"10","author":"Mandler","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb1235","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.intimp.2018.10.032","article-title":"An oligomer-specific antibody improved motor function and attenuated neuropathology in the SOD1-G93A transgenic mouse model of ALS","volume":"65","author":"Dong","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb1240","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"35","key":"10.1016\/j.ijbiomac.2021.03.113_bb1245","doi-asserted-by":"crossref","first-page":"30649","DOI":"10.1074\/jbc.C500288200","article-title":"Familial mutants of alpha-synuclein with increased neurotoxicity have a destabilized conformation","volume":"280","author":"Bertoncini","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb1250","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A beta component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.03.113_bb1255","first-page":"4883","article-title":"(\u2212)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson\u2019s disease","volume":"17","author":"Zhou","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb1260","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/ncomms1766","article-title":"The self-interaction of native TDP-43 C terminus inhibits its degradation and contributes to early proteinopathies","volume":"3","author":"Wang","year":"2012","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.ijbiomac.2021.03.113_bb1265","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1021\/jf070730r","article-title":"Permeability profile estimation of flavonoids and other phenolic compounds by biopartitioning micellar capillary chromatography","volume":"55","author":"Diniz","year":"2007","journal-title":"J. Agric. Food Chem."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2021.03.113_bb1270","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/10284150600637739","article-title":"Do flavan-3-ols from green tea reach the human brain?","volume":"9","author":"Zini","year":"2006","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb1275","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcis.2016.12.038","article-title":"Synergistic effects of negatively charged hydrophobic nanoparticles and (\u2212)-epigallocatechin-3-gallate on inhibiting amyloid \u03b2-protein aggregation","volume":"491","author":"Liu","year":"2017","journal-title":"J. Colloid Interface Sci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.03.113_bb1280","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/s41401-019-0243-7","article-title":"Increased BBB permeability contributes to EGCG-caused cognitive function improvement in natural aging rats: pharmacokinetic and distribution analyses","volume":"40","author":"Wei","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"42","key":"10.1016\/j.ijbiomac.2021.03.113_bb1285","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja206279b","article-title":"Lysine-specific molecular tweezers are broad-spectrum inhibitors of assembly and toxicity of amyloid proteins","volume":"133","author":"Sinha","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"14","key":"10.1016\/j.ijbiomac.2021.03.113_bb1290","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1021\/acs.jpcb.5b00692","article-title":"Amyloid \u03b2-protein assembly: the effect of molecular tweezers CLR01 and CLR03","volume":"119","author":"Zheng","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb1295","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2050-6511-15-23","article-title":"Safety and pharmacological characterization of the molecular tweezer CLR01 - a broad-spectrum inhibitor of amyloid proteins\u2019 toxicity","volume":"15","author":"Attar","year":"2014","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.03.113_bb1300","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/1567201043334542","article-title":"Drug delivery across the blood-brain barrier","volume":"1","author":"Chen","year":"2004","journal-title":"Curr. Drug Deliv."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.03.113_bb1305","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.7150\/thno.21254","article-title":"Current strategies for brain drug delivery","volume":"8","author":"Dong","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb1310","doi-asserted-by":"crossref","first-page":"2537698","DOI":"10.1155\/2019\/2537698","article-title":"Pathomechanisms of blood-brain barrier disruption in ALS","volume":"2019","author":"Kakaroubas","year":"2019","journal-title":"Neurosci. J."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.03.113_bb1315","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1021\/acs.molpharmaceut.7b00158","article-title":"Targeting the central nervous system (CNS): a review of rabies virus-targeting strategies","volume":"14","author":"Oswald","year":"2017","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.03.113_bb1320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/pharmaceutics12020093","article-title":"Targeting small molecule delivery to the brain and spinal cord via intranasal administration of rabies virus glycoprotein (RVG29)-modified PLGA nanoparticles","volume":"12","author":"Chung","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb1325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molmet.2017.12.001","article-title":"The LepR-mediated leptin transport across brain barriers controls food reward","volume":"8","author":"Di Spiezio","year":"2018","journal-title":"Mol. Metab."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.03.113_bb1330","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1016244500596","article-title":"Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate","volume":"12","author":"Pardridge","year":"1995","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.03.113_bb1335","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/0026-0495(87)90099-0","article-title":"Human blood-brain barrier transferrin receptor","volume":"36","author":"Pardridge","year":"1987","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb1340","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/978-1-4939-2806-4_21","article-title":"Applications of ApoB LDLR-binding domain approach for the development of CNS-penetrating peptides for Alzheimer\u2019s disease","volume":"1324","author":"Masliah","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.03.113_bb1345","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.ymthe.2017.03.037","article-title":"A basic ApoE-based peptide mediator to deliver proteins across the blood-brain barrier: long-term efficacy, toxicity, and mechanism","volume":"25","author":"Meng","year":"2017","journal-title":"Mol. Ther."},{"issue":"30","key":"10.1016\/j.ijbiomac.2021.03.113_bb1350","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb4429","article-title":"Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection","volume":"6","author":"Ma","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb1355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2017.05.024","article-title":"Angubindin-1, a novel paracellular absorption enhancer acting at the tricellular tight junction","volume":"260","author":"Krug","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb1360","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2018.05.010","article-title":"Angubindin-1 opens the blood-brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system","volume":"283","author":"Zeniya","year":"2018","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb1365","doi-asserted-by":"crossref","first-page":"e10143","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng Transl. Med."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.03.113_bb1370","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1038\/s41596-018-0066-x","article-title":"Blood\u2013brain-barrier organoids for investigating the permeability of CNS therapeutics","volume":"13","author":"Bergmann","year":"2018","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb1375","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12987-020-00183-7","article-title":"In vitro modeling of the neurovascular unit: advances in the field","volume":"17","author":"Bhalerao","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.ijbiomac.2021.03.113_bb1380","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.semcdb.2020.05.012","article-title":"Modelling neurodegenerative disease using brain organoids","volume":"111","author":"Wray","year":"2021","journal-title":"Semin. cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.03.113_bb1385","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.stemcr.2017.09.021","article-title":"Generation of a motor nerve organoid with human stem cell-derived neurons","volume":"9","author":"Kawada","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.03.113_bb1390","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/hmg\/ddm311","article-title":"Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic","volume":"17","author":"Takahashi","year":"2007","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.03.113_bb1395","first-page":"11","article-title":"Intracellular accumulation of toxic turn amyloid-\u03b2 is associated with endoplasmic reticulum stress in Alzheimer\u2019s disease","volume":"10","author":"Soejima","year":"2013","journal-title":"Curr. Alzheimer Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.03.113_bb1400","doi-asserted-by":"crossref","first-page":"1701930","DOI":"10.1183\/13993003.01930-2017","article-title":"Integration of multi-omics datasets enables molecular classification of COPD","volume":"51","author":"Li","year":"2018","journal-title":"Eur. Respir. J."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021006462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021006462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:52:34Z","timestamp":1758876754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813021006462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":280,"alternative-id":["S0141813021006462"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.03.113","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of amyloid oligomers in neurodegenerative pathologies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.03.113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}